Sen. McConnell: Democrats are jamming us with COVID-19 relief


WASHINGTON, DC – OCTOBER 06: Senate Minority Leader Mitch McConnell (R-Ky.) spoke to reporters on October 06, 2018 in Washington, D.C. (Photo by Chip Somodevilla/Getty Images)

OAN Newsroom
UPDATED 6:15 PM PT – Tuesday, March 2, 2021

Senate Minority Leader Mitch McConnell (R-Ky.) is calling for fellow Republicans to block Joe Biden’s nearly $2 trillion coronavirus relief package. On Tuesday, McConnell continued his attacks on Democrats for attempting to push the bill through Congress without Republican contribution.

He accused Democrats of taking advantage of the budget reconciliation process and trying to sidestep the Senate filibuster. McConnell also said they are trying to push proposals that are unrelated to the coronavirus pandemic.

“So, we’ll be fighting this in every way that we can. It is my hope that, in the end, Senate Republicans will unanimously oppose it just like House Republicans did,” McConnell stated. “I think it’s noteworthy to know we’re in the House. The only thing bipartisan about the proposal was the opposition to it.”

Senators are gearing up to vote on the package, which is expected to hit the Senate floor as early as this week.

MORE NEWS: Bipartisan Group Of Lawmakers Introduce Bill To Make Puerto Rico A State



Thank you for dropping in to My Local Pages and seeing this article on current USA Business and Political news published as “Sen. McConnell: Democrats are jamming us with COVID-19 relief”. This news update was brought to you by My Local Pages Australia as part of our news aggregator services.

#Sen #McConnell #Democrats #jamming #COVID19 #relief



Source link

Iran’s Mini-Submarine Force Is Dangerous (Thank North Korea)


Tensions continue to mount between Washington and Iran, with every week bringing forth a new round of diplomatic threats and accusations.

Most recently, Revolutionary Guards commander Maj. Gen. Hossein Salami gave a blistering speech in which he assured the Iranian parliament that the “vulnerability” of American aircraft carriers will prevent the U.S. military from challenging Iranian power in the Persian Gulf. Such rhetoric is par for the course for Iranian officials and state media, who project unwavering confidence in Iranian military capabilities.

But just how capable is Iran’s conventional military, and do they really have the means to effectively resist a U.S. offensive?

The National Interest previously looked at this nuanced question with overviews of Iran’s air force and surface navy. We now turn to what is arguably the core of Iran’s conventional military strength, and the reason why it boasts the fourth-strongest navy in the world: its submarine force.

Perhaps the most striking aspect of Iran’s submarine roster is its sheer size, especially in relation to the rest of its navy. Whereas Iran’s combined output of operational corvettes, frigates, and destroyers hardly exceeds 10, it currently fields a whopping 34 submarines. The vast majority of these are midget-class–or “littoral”–diesel-electric vessels, with roughly two dozen from Iran’s homemade Ghadir class and several more from the North Korean Yugo class. Impressively, the Ghadir is much smaller but still has strong offensive capabilities; Ghadir vessels boast the same 533 mm torpedo tubes as the handful of Iran’s much larger Kilo vessels, only fewer at two versus six.

To be sure, Iran’s heavy concentration of mini-submarines makes for unflattering comparisons with the much more robust submarine fleets of its American and Russian counterparts. However, their roster makes a great deal of military sense within the context of Iran’s strategic objectives. Iran has no need to project power sea power around the world, or even across the Middle East. Instead, the Iranian navy is constituted and organized around the specific goal of securing the Persian Gulf and specifically the Hormuz Strait. The limited range of Iran’s diesel-electric submarines is irrelevant in the restrictive and shallow confines of the Gulf, while their near-undetectability mine-laying capability makes them ideal candidates for patrol and ambush operations against hostile surface vessels. 

More recently, Iran has begun to diversify its indigenous submarine industry beyond the smallest vessels. The new Fateh class is intended to round out Iran’s lopsided roster, coming in between the Ghadir and Kilo classes at a displacement of 600 tons. In addition to the 533 mm torpedo tubes that are standard across Iran’s submarine force, Iranian state media reports that the Fateh vessels–of which there are two at the time of writing–can fire anti-ship cruise missiles from a submerged position.

Iran’s submarine force is by far the most numerous and technically capable arm of its navy and slated to remain so for the foreseeable future given Tehran’s geopolitical investment in the Gulf region. While it is still highly unlikely to match the U.S. Navy in any sort of pitched conflict, submarines would inevitably be the spearhead of a prospective Iranian anti-access/area-denial (A2/AD) campaign to seal the Hormuz Strait, or to stage a one-off surprise saturation attack against US defenses in the Persian Gulf.

Mark Episkopos is a frequent contributor to The National Interest and serves as research assistant at the Center for the National Interest. Mark is also a PhD student in History at American University.

Image: Reuters. 

Thank you for visiting My Local Pages and checking this news article involving USA and International news titled “Iran’s Mini-Submarine Force Is Dangerous (Thank North Korea)”. This article is presented by My Local Pages as part of our national news services.

#Irans #MiniSubmarine #Force #Dangerous #North #Korea



Source link

Review: ‘Klara and the Sun,’ by Kazuo Ishiguro


Klara’s optical responses to right and wrong are the affective computer’s version of an innate morality—her unnatural natural law. They’re also another way that Ishiguro turns robot stereotypes on their head. Many hands have been wrung (including mine) about nanny bots and animatronic pets or pals, which will be, or so we prognosticators have fretted, soulless and servile. They’ll spoil the children. But Klara does nothing of the sort. She’ll carry out orders if they’re reasonable and issued politely, but she does not respond to rude commands, and she is anything but spineless. No one instructs her to try to find a cure for Josie; she does that on her own. Everyone except Klara and Rick seems resigned to the girl’s decline. The problem is that the plan of action Klara comes up with is so bizarre that the reader may suspect her software is glitching.

Oddly enough, given its subject matter, Klara and the Sun doesn’t induce the shuddery, uncanny-valley sensation that makes Never Let Me Go such a satisfying horror story. For one thing, although Klara never describes her own appearance, we deduce from the fact that humans immediately know she’s an AF that she isn’t humanoid enough to be creepy. (Clones, by contrast, pass for human, because they are human.) Moreover, this novel’s alternate universe isn’t all that alternate. Yes, lifting has made the body more cyborgian while androids have become more anthropoid, but we’ve been experiencing that role reversal for some time now. Otherwise, the setting parallels our own: It has the same extreme inequalities of wealth and opportunity, the same despoiled environment, the same deteriorating urban space. Even the sacrifice of children to parental fears about loss of status seems sadly familiar.

And Klara and the Sun doesn’t strive for uncanniness. It aspires to enchantment, or to put it another way, reenchantment, the restoration of magic to a disenchanted world. Ishiguro drapes realism like a thin cloth over a primordial cosmos. Every so often, the cloth slips, revealing the old gods, the terrible beasts, the warring forces of light and darkness. The custom of performing possibly lethal prosthetic procedures on one’s own offspring bears a family resemblance to immolating them on behalf of the god Moloch.

We can perceive monstrosity (or fail to perceive it), but Klara can see monsters. Crossing a field on the way to the waterfall with the Mother, Klara spots a bull, and grows so alarmed that she cries out. Not that she hadn’t seen photos of bulls before, but this creature

gave, all at once, so many signals of anger and the wish to destroy. Its face, its horns, its cold eyes watching me all brought fear into my mind, but I felt something more, something stranger and deeper. At that moment it felt to me some great error had been made that the creature should be allowed to stand in the Sun’s pattern at all, that this bull belonged somewhere deep in the ground far within the mud and darkness, and its presence on the grass could only have awful consequences.

Klara is allowed to stand in the pattern of the Sun. Ishiguro has anointed her, a high-tech consumer product, the improbable priestess of something very like an ancient nature cult. Gifted with a rare capacity for reverence, she tries always to remember to thank the Sun for sustaining her. Her faith in him is total. When Klara needs help, she goes to the barn where she believes he sets, and there she has the AI equivalent of visions. Old images of the store jostle against the barn’s interior walls. So do new ones: Rosa lies on the ground in distress. Klara fears that her petition may have angered the Sun, but then the glow of the sunset takes on “an almost gentle aspect.” A piece of furniture from the store, the Glass Display Trolley, rises before her, as if assumed into the sky. The robot has spoken with her god, and he has answered: “I could tell that the Sun was smiling towards me kindly as he went down for his rest.”

Thank you for dropping in to My Local Pages and seeing this news article on USA news called “Review: ‘Klara and the Sun,’ by Kazuo Ishiguro”. This news release is presented by MyLocalPages Australia as part of our national news services.

#Review #Klara #Sun #Kazuo #Ishiguro



Source link

Stop writing – Covid-19 has boosted the campaign against exams in American schools | United States


Thank you for spending your time with us on My Local Pages. We hope you enjoyed checking this article involving the latest USA News items named “Stop writing – Covid-19 has boosted the campaign against exams in American schools | United States”. This article is presented by My Local Pages as part of our USA news services.

#Stop #writing #Covid19 #boosted #campaign #exams #American #schools #United #States



Source link

Trump’s Protectionist Failure – WSJ


Donald Trump was America’s first post-Depression presidential nominee to make protectionism a major plank of his platform. During the 2016 campaign he presented it, along with tax cuts and deregulation, as an antidote to President Obama’s weak economic recovery—the weakest of the postwar period. In his first two years as president, Mr. Trump lifted regulatory burdens and pushed through a major tax cut, which triggered a broad-based rise in income and employment. He then turned to his protectionist agenda, which reduced economic growth and failed to deliver Michigan, Pennsylvania or Wisconsin in the 2020 election. Protectionism failed both as economic policy and political strategy.



Photo:

David Klein

Much of the allure of U.S. postwar protectionism comes from nostalgia for an enduring myth: the “golden age of American manufacturing.” There was a manufacturing bonanza in the 1950s and ’60s, but it wasn’t engineered by policy makers then and couldn’t be replicated now. It was an unsustainable anomaly created by World War II.

The U.S. emerged from the war with an almost totally new industrial base, a carry-over from a wartime role as “the great arsenal of democracy.” With much of the rest of the developed world in rubble, America enjoyed a virtual monopoly in heavy manufacturing for a quarter-century. In the 1950s, real average hourly earnings in manufacturing leapt 34.5%—seven times their growth in the 1970s.

By the mid-1970s, Europe and Japan had risen from the ashes of the war and South Korea and Taiwan had industrialized. By 1976, U.S. manufacturing exports had returned to prewar levels, as a percentage of global exports, and after 1979 U.S. manufacturing employment fell in absolute terms as a push was undertaken to automate, reduce labor costs and regain competitiveness. While manufacturing jobs declined from 32% of total employment in 1953 to 8.7% in 2015, manufacturing as a share of real gross domestic product has remained virtually constant due to increases in productivity.

As Mr. Trump found when he imposed tariffs on steel and aluminum, the resulting increase in jobs in those industries was small. This shouldn’t have come as a surprise: In 1980 it took 10.1 man-hours to produce a ton of steel. Thanks to automation, that was down to 1.5 man-hours a ton in 2017, with some steel makers achieving 0.5. Jobs gained in the steel and aluminum industries after the tariffs were dwarfed by jobs lost in industries that use steel and aluminum in their manufacturing process, not to mention the jobs lost due to foreign trade retaliation.

The uncertainty concerning which industry would be hurt next caused private investment to decline across the economy. GDP growth, which had been accelerating in 2017 and 2018, fell 20% in 2019, from 2.9% to 2.3%, in line with the Congressional Budget Office estimates of the negative effect of the protectionist policies.

Protectionism even hurt manufacturing in the states it was supposed to help. According to the Bureau of Labor Statistics, manufacturing employment in Michigan, Pennsylvania and Wisconsin, which had increased in 2017 and 2018, started to fall in 2019 as the trade war intensified.

The notion that protectionism could bring back millions of manufacturing jobs and attract a significant number of votes in the industrial states was outdated, as was the trade debate itself. For instance, trade deficits become meaningless when so much U.S. content is embedded in the value of imports such as tech products, and when most imports from Mexico, Canada and even China are produced by U.S. companies owned by U.S. pension funds—and therefore by U.S. workers.

Most Americans no longer see protectionism as helpful or feasible. In 2016, 72% of Americans viewed foreign trade as an opportunity for economic growth rather than a threat, the highest approval rating since Gallup started asking. By 2020, approval had risen to 79%.

If Mr. Trump’s trade message helped him in the 2016 election, it was because he was expressing concern about the plight of working people who had suffered disproportionately during the Obama “secular stagnation,” not because protectionism itself was popular. Even among Trump supporters, a post-2020 election poll by YouGov showed that 60% believed foreign trade helps the economy. The voting pattern of Lordstown, Ohio—where Mr. Trump promised in 2017 to save local factory jobs—suggests that it was the concern Mr. Trump expressed, not his ability to save the General Motors plant, that attracted their votes in the first place. The plant closed anyway, and the area voted for Mr. Trump in 2020 by an even bigger margin than in 2016.

As the pay premium for having a college degree relative to a high-school diploma almost doubled from 1967 to 2017, blue-collar America fell further behind. Over the same period, the explosion of transfer payments caused the labor-force participation rate of the bottom quintile of earners to collapse. By 2017, government transfer payments rose to constitute more than 91% of their $49,613 average income. Government payments to nonworkers approached the after-tax incomes of blue-collar workers, spawning resentment. Hillary Clinton’s expressions of contempt only heightened the sense that America had lost interest in and respect for its workers, and helped make Mr. Trump’s expression of concern resonate.

For these workers, the Trump tax cut and deregulatory effort delivered, as blue-collar wages grew faster than white-collar wages. In 2019 the poverty rate hit a record low. Real household income leapt by $4,379, 13 times the average annual postwar gain. If the growth surge of 2017-18 had continued through 2019, these landmark economic achievements would have been even stronger—perhaps strong enough to have overcome in 2020 the political effects of the coronavirus shutdown and voters’ personal aversion to Mr. Trump.

America is now so integrated into the global economy that jobs cannot be created or protected by protectionist policies. Innovation, technological development and the capacity of a market economy to adapt to change provide our only sure path to job creation and prosperity. This is a lesson all politicians, but especially Republicans, need to learn from the economic and political failure of protectionism in the Trump era.

Mr. Gramm is a former chairman of the Senate Banking Committee and a visiting scholar at the American Enterprise Institute. Mr. Toomey, a Republican, is a U.S. senator from Pennsylvania.

Mike Solon

contributed to this article.

Copyright ©2020 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

Thanks for checking this story about current USA news named “Trump’s Protectionist Failure – WSJ”. This story was posted by My Local Pages Australia as part of our local and national news services.

#Trumps #Protectionist #Failure #WSJ



Source link

Frida Mom commercial during the Golden Globes portrayed how difficult breastfeeding is


“Breast is best” was a phrase I had heard long before I pushed my 6-pound, 12-ounce son into the world. Very few people, including the labor and delivery nursing staff, made it a point to simply ask if I even planned on breastfeeding — it was assumed I would. So when my newborn arrived after more than 24 hours of intense and painful labor, he was immediately pushed toward my breasts. To be honest, even the joy of seeing his face for the very first time did not erase the fatigue of that moment, nor the slight sliver of resentment I felt at the thought of instantly becoming my son’s de facto milk bottle.

Thank you for stopping to visit My Local Pages. We Hope you enjoyed checking this news update about the latest USA Business news items published as “Frida Mom commercial during the Golden Globes portrayed how difficult breastfeeding is”. This news update was posted by MyLocalPages Australia as part of our national news services.

#Frida #Mom #commercial #Golden #Globes #portrayed #difficult #breastfeeding



Source link

Democrats may consider minimum wage compromise as opportunity narrows


Is any increase better than no increase?

That may be the question some Senate Democrats are asking themselves as they try to pass a $15-an-hour minimum wage hike inside the $1.9 trillion COVID-19 relief package that seems to be almost impossible.

Democrats have made it clear that they want to increase the federal minimum wage to that number, but last week were dealt an almost fatal blow when the Senate’s parliamentarian ruled that the hike should not be included in the measure.

There also seems to be no serious hope that the Senate will eliminate the filibuster. Politico reported Monday that the party “could be at risk of getting nothing unless it engages with Republicans.”

Democrats have a 10-vote edge in the House and are tied in the Senate 50-50. Democratic Sens. Joe Manchin of West Virginia and Kyrsten Sinema of Arizona have voiced opposition to the minimum wage hike in the relief bill, and other moderates have expressed concerns, too.

In order for the Senate to pass the bill—with the wage hike included— it would need every Democrat and win over 10 Republicans to hit the 60-vote threshold. The number is impossible with the minimum wage addition the way it is currently written. But some Republicans seem willing to negotiate.

Sens. Tom Cotton and Mitt Romney wrote on FoxNews.com on Monday that it is time for an increase to the minimum wage.

GET THE FOX NEWS APP

But they wrote, “Many Democrats are hung up on an unserious scheme to raise the minimum wage to $15 an hour. Their plan doesn’t have the votes to pass, and even if it did, a $15 minimum wage would destroy 1.4 million jobs, according to the nonpartisan Congressional Budget Office (CBO).”

REP. KEVIN McCARTHY: DEMS’ $1.9 TRILLION COVID BILL IS NOT RESCUE OR RELIEF PLAN, IT’S A PELOSI PAYOFF

Their bill, which is called, the Higher Wages for American Workers Act, “would raise the federal minimum wage to $10 an hour over time and make sure all the gains go to legal workers, not illegal immigrants.”

CLICK HERE TO GET THE OPINION NEWSLETTER

Sen. Susan Collins, R-Maine, who is considered a moderate, told Politico that she does not understand the “all-or-nothing approach.”

“Going from $7.25 to 10 dollars an hour … is a substantial and long-overdue increase. So why would the progressives to whom [Sen.] Chuck [Schumer] is clearly listening be opposed to that? It sounds like Chuck wants an issue, not a solution.”

The Associated Press contributed to this report

Thank you for checking out this news article regarding the latest USA News items named “Democrats may consider minimum wage compromise as opportunity narrows”. This news update was brought to you by MyLocalPages Australia as part of our USA news services.

#Democrats #minimum #wage #compromise #opportunity #narrows



Source link

Covid-19: The U.S. Is Edging Toward Normal, Alarming Some Officials


Credit…Frederic J. Brown/Agence France-Presse — Getty Images

Tens of thousands of students walked into classrooms in Chicago public schools on Monday for the first time in nearly a year. Restaurants in Massachusetts were allowed to operate without capacity limits, and venues like roller skating rinks and movie theaters in most of the state opened with fewer restrictions. And South Carolina erased its limits on large gatherings.

Across the country, the first day of March brought a new wave of reopenings and liftings of pandemic restrictions, signs that more Americans are tentatively emerging from months of isolation, even if not everyone agrees the time is ripe.

There are plenty of reasons for optimism: Vaccinations have increased significantly in recent weeks, and daily reports of new coronavirus cases have fallen across the country from their January peaks.

In Kentucky, all but a handful of school districts are now offering in-person classes, while the state races to vaccinate teachers as quickly as possible. Gov. Andy Beshear told reporters last week that the state’s falling Covid infection statistics showed that immunizations were beginning to make an impact.

“It means vaccinations work,” he said. “We’re already seeing it. We’re seeing it in these numbers. It’s a really positive sign.”

Dr. Anthony S. Fauci, President Biden’s chief medical adviser for Covid-19, said at a news briefing on Monday that for small groups of people who have all been fully vaccinated, there was a low risk in gathering together at home. Activities beyond that, he said, would depend on data, modeling and “good clinical common sense,” adding that the Centers for Disease Control and Prevention would soon have guidance for what vaccinated people could do safely.

The positive signs come with caveats. Though the national statistics have improved drastically since January, they have plateaued in the last week or so, and the United States is still reporting more than 65,000 new cases a day on average — comparable to the peak of last summer’s surge, according to a New York Times database. The country is still averaging more than 2,000 deaths per day, though deaths are a lagging indicator because it can take weeks for patients to die.

New, more contagious variants of the virus are circulating in the country, with the potential to push case counts upward again. Testing has fallen 30 percent in recent weeks, leaving experts worried about how quickly new outbreaks will be known. And millions of Americans are still waiting to be vaccinated.

Given all that, some experts worry that the reopenings are coming a bit too soon.

“We’re, hopefully, in between what I hope will be the last big wave, and the beginning of the period where I hope Covid will become very uncommon,” said Robert Horsburgh, an epidemiologist at the Boston University School of Public Health. “But we don’t know that. I’ve been advocating for us to just hang tight for four to six more weeks.”

The director of the C.D.C., Dr. Rochelle Walensky, said at the briefing on Monday that she was “really worried” about the rollbacks of restrictions in some states. She cautioned that with the decline in cases “stalling” and with variants spreading, “we stand to completely lose the hard-earned ground we have gained.”

The plateauing case levels “must be taken extremely seriously,” Dr. Walensky warned at a briefing last week. She added: “I know people are tired; they want to get back to life, to normal. But we’re not there yet.”

After some counties in Washington State allowed movie theaters to reopen, Nick Butcher, 36, made up for lost time by attending screenings of the “Lord of the Rings” trilogy for three straight nights. He bought some M&Ms at the concession stand, sat distanced from others in the audience, and said he felt as though things were almost back to normal.

“I’m actually getting optimistic, over all,” said Mr. Butcher, a software engineer at Microsoft who recently recovered from a case of Covid-19, as did several relatives. “This week is one of the first times I’ve gone into my office almost since the pandemic started.”


United States ›United StatesOn March 114-day change
New cases56,672–21%
New deaths1,425–17%

World ›WorldOn March 114-day change
New cases293,587+2%
New deaths6,610–21%

U.S. vaccinations ›

Where states are reporting vaccines given

A first dose of the Oxford-AstraZeneca vaccine substantially reduced the risk of older people becoming ill with Covid-19, scientists in Britain reported on Monday, the strongest sign yet that a shot that much of the world is relying on to end the pandemic will protect the elderly.

Four weeks after the first dose, the vaccine was roughly 60 percent effective in preventing Covid-19 among people at least 70 years old in England, the scientists wrote in a paper that was posted online on Monday but not yet published in a journal or vetted by other researchers.

That figure appeared to rise in the following week, though there was a high level of statistical uncertainty in the subsequent number.

For countries across Europe that have been hesitant about authorizing the AstraZeneca vaccine for use in older people, the data could resolve some of those doubts. The early clinical trials of the AstraZeneca vaccine did not enroll as many older people as the trials of other shots, making a number of European countries uneasy about using it in that age group.

But Britain decided to authorize the vaccine for people of all ages, creating a valuable store of data on its effectiveness.

In France, one of the countries that had restricted the AstraZeneca vaccine to younger people, the country’s health minister said people over 65 with pre-existing conditions would be able to receive the vaccine, Reuters reported.

In part because of the age restrictions, countries across Europe have been slow to use their doses of the AstraZeneca vaccine, with some health workers holding out for the Pfizer-BioNTech vaccine instead.

The same study from England showed strong protection from the Pfizer vaccine. Among people at least 70 years old, a first dose was 61 percent effective in preventing Covid-19 up to four weeks after the shot, a figure that then plateaued, the study said.

In people at least 80 years old, a first dose was 70 percent effective at preventing Covid-19 four weeks later, a figure that rose to 89 percent two weeks after the second shot. (Britain has decided to delay second doses of both the Pfizer and AstraZeneca shots up to 12 weeks after the first.)

“The results demonstrate that a single dose of either the Pfizer-BioNTech or the Oxford-AstraZeneca vaccine provides a high level of protection against severe disease in the most vulnerable age groups,” Azra Ghani, a professor of infectious disease epidemiology at Imperial College London, said of the findings.

Because Britain authorized the AstraZeneca vaccine later than the Pfizer vaccine, there is less data on the effectiveness of a full two-dose course of the AstraZeneca vaccine.

Both vaccines were also highly effective at preventing coronavirus-related hospitalizations in the study from England.

The study was part of a wealth of data that has emerged from Britain’s mass inoculation program showing that the vaccines were working as intended. No other large nation is inoculating people as quickly as Britain, the first country in the world to authorize and begin using both the Pfizer shot and the one developed by AstraZeneca and the University of Oxford.

California lawmakers and Gov. Gavin Newsom on Monday announced a plan intended to encourage districts to reopen schools, the latest state to take the step that has drawn contentious deliberations across the country.

The agreement includes $2 billion in incentives and fast-tracked vaccinations to lure teachers back for at least some of the remaining school year.

President Biden has pushed for schools to safely reopen, even if that means limited in-person learning, having called for them to be open five days a week, but has been vague about what that would look like. Less than half of students in the United States are attending public schools that offer traditional full-time schedules, frustrating both parents and educators.

In Philadelphia, elected officials, teachers’ unions and health agencies have urged strict caution, putting most districts on hybrid schedules, while some remain fully remote. In the city itself, the teachers’ union and district reached a reopening deal to return students in kindergarten through the second grade to classrooms in phases over the month of March. The city is expediting teacher vaccination and purchasing air purifiers, and hopes to return older students to school before the end of the academic year.

The new schools chancellor in New York City, the largest public school district in the country, pledged on Friday to at least partially reopen high schools by the end of the year. While the city’s schools were among the first in the country to reopen last fall, the in-person learning has been inconsistent because of the virus, and high schools have been closed since November.

The new measures in California come as the state emerges from a towering post-holiday spike in coronavirus cases. The aim is to restore six to 12 weeks of in-person class for the regular school year, which ends in late June in most of the state’s districts. Most of California’s six million schoolchildren have been receiving only remote instruction for the past year.

Rather than mandating reopening, the state will make a time-limited offer of grants to help pay for coronavirus testing, upgraded ventilation and other campus safeguards, along with $4.6 billion for extended class time and summer school.

The money is modest by California standards. The state spent nearly $100 billion last year on its public school system, and the $2 billion pot will be open to more than 1,000 school districts. Those with plans to reopen after March 31 will be eligible for less money, with grants shrinking to zero for schools opening after May 15.

And reopenings are likely to be limited, particularly where the virus and its variants are still surging. In counties with the state’s highest-risk “purple” designation — Los Angeles, for instance — schools will only have to offer face-to-face class for high-needs students and children in transitional kindergarten through second grade to be eligible for reopening money.

In lower-risk counties, districts applying for the grants also will have to offer face-to-face class in elementary schools and at least one middle school and one high school grade.

But the incentives, along with the governor’s promise last week to earmark 10 percent of new first doses of vaccines for school employees, establish California’s clearest blueprint so far for restoring in-person instruction for the bulk of the state’s six million-plus public school students. And they address key demands of the state’s powerful teachers’ unions. Most large districts, including those in Los Angeles, San Diego and San Francisco, have been operating remotely for the vast majority of students for nearly a year.

On Monday, Austin Beutner, the Los Angeles district’s superintendent, said Mr. Newsom had procured enough vaccine doses for its schools to inoculate 40,000 teachers, bus drivers, custodians and other school employees within the next two weeks — enough to reopen Los Angeles classrooms at least through second grade by mid- to late April if school employee unions comply.

Leaders of United Teachers Los Angeles, which represents educators in the nation’s second-largest school district, have asked members to vote this week on a proposed endorsement of their conditions for an in-person return, which include teacher vaccines, stringent health measures and a potential sticking point: a rate of community transmission that is significantly lower than present before schools can reopen.

California school districts need agreements with their unions in order to reopen, although most of the state’s other large districts have already worked out at least a framework for an in-person return.

Long Beach, where city and school district officials have been working together to vaccinate teachers since January, for instance, are on track to resume in-person classes on March 31. And the schools in Elk Grove, near Sacramento, have said elementary students there could be back in classrooms, at least part time, by the middle of this month.

Dana Goldstein contributed reporting.

Extraordinarily high staff turnover at U.S. nursing homes most likely contributed to the shocking number of deaths at the facilities during the pandemic, the authors of a new study suggested.

The study, which was published Monday in Health Affairs, a health policy journal, represents a comprehensive look at the turnover rates in 15,645 nursing homes across the country, accounting for nearly all of the facilities certified by the federal government. The researchers found the average annual rate was 128 percent, with some facilities experiencing turnover that exceeded 300 percent.

Researchers pointed to the findings to urge Medicare to publish the turnover rates at individual nursing home sites, as a way of putting a spotlight on substandard conditions and pressuring owners to make improvements.

Inadequate staffing and low pay have long plagued nursing homes and quality of care for the more than one million residents who live in these facilities. But the pandemic has exposed these issues even more sharply, with investigations underway into some states’ oversight of the facilities as Covid-19 cases spiraled unchecked and deaths skyrocketed.

The high turnover rate most likely made it harder for nursing homes to put in place strong infection controls during the pandemic, and led to rampant spread of the coronavirus, said Ashvin Gandhi, the lead author and a health economist and assistant professor at the University of California Los Angeles Anderson School of Management.

Nursing-home owners blame inadequate reimbursement from Medicaid, the federal-state program for elderly skilled nursing care.

“Workforce recruitment and retention is among the most pressing challenges confronting long-term care providers, and we have been calling for help for years,” Dr. David Gifford, the chief medical officer for the American Health Care Association and National Center for Assisted Living, a trade group, said in an emailed statement.

“It’s high past time that providers receive the proper resources to invest in our frontline caregivers in order to improve quality care,” he said.

Credit…Julie Bennett/Associated Press

Nursing home staff members have also shown resistance to getting vaccinated against the coronavirus. If a nurse who was immunized leaves and is replaced, the facility will need to ensure the new employee is also vaccinated, especially given the reluctance of some workers to get a coronavirus shot.

“Trying to do a one-shot vaccination push isn’t enough,” Dr. Gandhi said. “You need continued vaccination outreach.”

New York City added workers in the food service and hotel industries to the list of people eligible for coronavirus vaccination on Monday, the same day the governors of Florida and Ohio announced expansions for eligibility in their states.

The expansions come as the supply of vaccines being distributed nationally is ramping up, and after a third vaccine, a single-shot dose from Johnson & Johnson, was authorized for emergency use by the Food and Drug Administration over the weekend. The pace of U.S. vaccinations is again accelerating, up to about 1.82 million doses per day on average, according to a New York Times database, above last month’s peak before snowstorms disrupted distribution.

In New York City, people who work in regional food banks, food pantries and “permitted home-delivered” meal programs became eligible on Monday to receive a vaccine. Hotel workers who have direct contact with guests also became eligible.

The governor of Florida, Ron DeSantis, said on Monday that people 50 and older who work in K-12 schools, law enforcement or firefighting would become eligible on Wednesday. Florida was one of the first states that decided to vaccinate anyone 65 and older, even before most essential workers, which led to long lines and confusion.

Gov. Mike DeWine of Ohio said on Monday that the state would receive more than 448,000 doses this week, including more than 96,000 doses of the Johnson & Johnson vaccine. He said that “in response to this significant increase in the amount of vaccine coming into Ohio,” a new group of people would be eligible on Thursday to get a shot.

That group includes people with Type 1 diabetes, pregnant women and certain workers in child care and funeral services, as well as law enforcement and corrections officers.

To stay ahead of more contagious and possibly more deadly virus variants, states have been racing to ramp up vaccinations and expand eligibility. But they have often done so before the supply could increase quickly enough, creating shortages and making it harder for people to get vaccination appointments.

Widespread testing is crucial in controlling the spread of the coronavirus and squashing new outbreaks, experts say. But the amount of testing in the United States has fallen by 30 percent in recent weeks.

From a high of nearly 14 million tests a week in early January, the pace fell to fewer than 10 million — a level not seen since October —  in the week ended Feb. 24, according to the Covid Tracking Project.

Some areas report even sharper declines: Michigan is testing about half as many people now as it was in November, and Delaware’s state-run sites are testing about one-third as many. Los Angeles County’s sites, which were running flat out last month, tested just 35 percent of their capacity last week.

Experts cited a number of factors that could be contributing to the slump:

All those forces may be at play, said Dr. Jennifer Nuzzo of the Johns Hopkins Bloomberg School of Public Health: “My sense is that it’s probably that there are fewer options for testing, fewer communications about it, people may be perceiving that it’s less necessary — maybe they just don’t see the point any more.”

The slump in testing, at a time when a clear picture of the pandemic is still badly needed, worries some epidemiologists. “There’s nothing about the current situation that has made testing any less necessary,” Dr. Nuzzo said.

Among other things, less testing makes it harder to follow the virus’s mutations and to get ahead of variants that may be more contagious or deadly, said Dr. Rick Pescatore, the chief physician at the Delaware Division of Public Health. “We can’t identify variants until we first identify positives.”

But the decline in testing may not be a cause for alarm — and may even be a good sign — if it reflects wider progress in tamping down the pandemic, said Dr. Clemens Hong, who runs Los Angeles County’s testing program.

“The biggest reason for the drop in testing demand, I think, is the decrease in infections and spread,” Dr. Hong said. “Covid-19 is not spreading as quickly right now, which means there’s fewer people with symptoms, and also fewer people having contact with people with Covid-19. That’s just the reality.”

Across the country, new case reports have dropped sharply since mid-January. At its peak on Jan. 8, the U.S. reported a seven-day average of over 259,000 new cases. Now, the seven-day average is less than 70,000, as of Saturday.

Hospitalizations and deaths have followed suit, and vaccine distribution is rapidly increasing: 15 percent of the U.S. population has now received at least one dose.

Nonetheless, Dr. Hong said, testing remains vital to getting ahead of outbreaks.

“Even with all these declines and the rollout of the vaccines, it’s just not enough,” he said. “We don’t have enough immunity in the community to prevent another surge. We may never see a surge like we saw in December and January again, but we’ll see little pockets and little surges that will try to come to life, and we just need to put them out.”

Johnson & Johnson said it would start shipping millions of doses early this week after the Food and Drug Administration granted emergency use authorization for its vaccine on Saturday.CreditCredit…Pool photo by Timothy D. Easley

When Johnson & Johnson’s coronavirus vaccine won emergency use authorization on Saturday from the Food and Drug Administration, the move augmented the nation’s vaccination effort with a third major tool — one that differs markedly from the first two authorized vaccines, made by Pfizer-BioNTech and Moderna.

Most notably, it is administered in a single dose instead of two, and can be kept unfrozen in an ordinary refrigerator for up to three months — features that promise greater flexibility as public health officials try to immunize Americans as quickly as possible.

Much is still to be determined about how this new tool will be used. Here is what we know so far.

Within the next few days. Johnson & Johnson started shipping out doses on Monday, and they can be used as soon as they reach vaccination sites starting on Tuesday.

At first, the increase in availability will be limited. The company had about 3.9 million doses on hand to ship right away, but after that, deliveries could be patchy for a few weeks. (For comparison, the nation is using up that many doses of the Pfizer-BioNTech and Moderna vaccines in a little more than two days.)

By the end of March, Johnson & Johnson says it will ship roughly 16 million more doses. Even so, the Pfizer-BioNTech and Moderna vaccines will continue to make up the majority of the nation’s supply.

The same way the two earlier vaccines are: in proportion to each state or territory’s population.

That’s still under discussion. The Centers for Disease Control and Prevention has said that the vaccine can be given to people 18 and over, and state officials are working out what their policies will be.

Because the new vaccine is given in a single shot and doesn’t require cold storage, some experts and officials have suggested directing it toward hard-to-reach segments of the population (like rural residents or homeless people), or to people who might not keep an appointment for a second shot (like college students or those with mobility issues).

But there is concern about appearing to favor or disfavor some groups, and the Biden administration has said it will insist that the new vaccine be distributed equitably.

That’s not clear. Right now, people are getting whichever vaccine the site has on hand when their turn comes, and appointment scheduling systems generally don’t tell users beforehand which it will be. Depending on how states decide to deploy the Johnson & Johnson vaccine, though, it may be possible to effectively choose what you get by choosing where you sign up to get it.

Health experts say the best shot is the one you can get the soonest, whichever one it turns out to be. All three authorized vaccines are highly protective, and the differences among them pale in comparison, they say, with the risk you would run by being picky and passing up a chance to get a shot because it was not your top choice.

A Frontier Airlines flight from Miami to La Guardia Airport in New York was canceled on Sunday night after a large group of passengers, including several adults, refused to wear masks, the airline said.

By Monday morning, the airline was facing accusations of anti-Semitism for its treatment of the passengers, who are Hasidic Jews, as well as demands for an investigation from the Anti-Defamation League of New York and other groups. Frontier steadfastly held to its position that the passengers had refused to comply with federal rules requiring them to wear masks.

Several phone videos that have surfaced do not show the confrontation that took place between the passengers and the Frontier crew members, only the aftermath. The video footage from inside the aircraft appeared to show members of the group wearing masks. Some passengers said that the episode escalated because just one member of the group, a 15-month-old child, was not wearing one.

Videos of the passengers exiting the plane amid chaos, captured by other people on the flight, were posted on Twitter by the Orthodox Jewish Public Affairs Council. In one video, a passenger says, “This is an anti-Semitic act.”

Another video showed a couple holding a maskless baby in a car seat, as children could be heard crying and a woman explained that the young children in their group, sitting in the back of the plane, had taken off their masks to eat.

A Frontier Airlines spokeswoman said in a statement that “a large group of passengers repeatedly refused to comply with the U.S. government’s federal mask mandate.”

GLOBAL ROUNDUP

Video

Video player loading
On Monday, Prime Minister Narendra Modi of India was vaccinated against the coronavirus. The country is beginning a large inoculation effort using the Oxford-AstraZeneca and the Covaxin vaccines.CreditCredit…India’s Press Information Bureau, via Reuters

NEW DELHI — Prime Minister Narendra Modi of India was vaccinated against the coronavirus on Monday as the country began the next phase of its inoculation drive, one of the largest in the world.

India has approved two coronavirus vaccines for emergency use: the Oxford-AstraZeneca vaccine, which is produced by the Serum Institute of India, the world’s largest vaccine producer; and Covaxin, which was developed by Bharat Biotech, an Indian pharmaceutical company.

Mr. Modi received the first of two doses of Covaxin, in line with his pitch for a “self-reliant India,” which he reiterated in his monthly radio address over the weekend. “The first condition for self-reliance is to have pride in the things of one’s own country,” he said.

Mr. Modi’s appeal to “make India Covid-19 free” comes at a time when vaccine hesitancy in the country is high, with 58 percent of respondents in one survey expressing doubts. India has managed to inoculate only about 14 million of its 1.3 billion people since its inoculation drive began this year.

As of Monday, vaccine eligibility in India has been expanded to include anyone 60 and older, as well as people 45 and older with chronic conditions such as heart disease, diabetes and hypertension.

Last month, India appeared to be experiencing something of a breather in its outbreak. The country has registered more than 11.1 million total cases, the second-highest tally in the world, after that of the United States, according to a New York Times database. Cases are again increasing.

On Sunday, the chief minister of the state of Maharashtra, which includes the country’s financial capital, Mumbai, imposed a lockdown in some areas after cases there surged.

In other global developments:

  • As most of Italy struggles to fight back coronavirus infections, the authorities on the island of Sardinia on Monday all but lifted restrictions. For the first time in months, locals will be able to eat in restaurants at night and stay outside past 10 p.m. Masks and social distancing will still be mandatory. Christian Solinas, the region’s president, said it was “a great result reached thanks to the sacrifices of all Sardinians.”

  • The Czech Republic, which is enduring one of the world’s worst coronavirus outbreaks, rolled out new restrictions on Monday limiting travel and closing schools, Reuters reported. About 26,000 police officers and 3,800 soldiers were deployed to enforce the orders.

  • The first doses distributed through the Covax program, which focuses on providing the vaccine to lower-income countries, were administered in Ghana and Ivory Coast on Monday, the World Health Organization said. The president of Ghana, Nana Akufo-Addo, and his wife received the shot at a military hospital, saying on Twitter that the vaccine — branded Covishield and developed by Oxford University and AstraZeneca — is safe and “a major catalyst to restoring livelihoods.”

  • Colombia on Monday became the first country in the Americas to receive a shipment of vaccines through the Covax program. That delivery was part of a “first wave” initiative that gives some countries an “early delivery of a limited number of doses” of the vaccine developed by Pfizer and BioNTech, the World Health Organization said.

  • The Philippines, which has had one of the worst coronavirus outbreaks in Southeast Asia, began its inoculation campaign on Monday even as the government struggled to reassure a population wary of foreign-made vaccines. The Philippines, a nation of more than 100 million, is among the last Southeast Asian countries to receive any coronavirus shots but aims to vaccinate 70 million people this year.

  • After months of coronavirus restrictions, a surge of shaggy-haired customers in Germany were able to walk into hair salons and barber shops — some of which opened their doors at 12:01 a.m. with champagne and confetti to celebrate the reopenings. Other stores, like nurseries, flower shops and nail salons, were also allowed to reopen on Monday, but all must adhere to strict rules on social distancing and mask wearing.

  • The health minister of Somalia on Monday proposed closing all schools and universities, as well as doubling down on other measures like social distancing and prohibiting large gatherings, as the country faces a worsening outbreak amid an impasse over elections.

  • Officials in Britain were frantically searching on Monday for someone who tested positive for the coronavirus variant first detected in Brazil. The person’s identity and whereabouts were a mystery: The person neglected to fill out an information card that accompanied a test kit, sending British officials on a quest to use postal service data to track them down.

Former President Donald Trump and former First Lady Melania Trump before boarding Air Force One for his last time as President on January 20, 2021.
Credit…Pete Marovich for The New York Times

Former President Donald J. Trump and his wife, Melania, quietly received coronavirus vaccinations in January before leaving the White House, an adviser said on Monday.

The news came a day after Mr. Trump appeared at the CPAC political conference in Orlando, Fla., where for the first time he encouraged people to go get vaccinated.

“Everyone should go get your shot,” Mr. Trump said during the speech. When The Times asked an adviser to the former president whether he had received his, the answer was that he had, in private, a month earlier.

The secret approach by Mr. Trump came as a number of his supporters have expressed resistance to the vaccine, and as other officials have tried setting an example by getting the shot in public.

President Biden, Vice President Kamala Harris and former Vice President Mike Pence received vaccine shots in front of television cameras.

Mr. Trump’s concern about the vaccine has generally been about whether he is getting credit for its development while he was president. He never publicly encouraged people to take it while he was in office; the first vaccines were approved shortly after Election Day.

The adviser did not say whether Mr. Trump received both his first and second shots of the vaccine in January, or if the second one was at another time.

Mr. and Mrs. Trump were both infected with the coronavirus in the fall, and the former president was hospitalized with a severe case.

Health care workers in the Covid-19 Unit at United Memorial Medical Center in Houston.
Credit…Mark Felix/Agence France-Presse — Getty Images

Every coronavirus variant of concern to researchers around the world has been circulating in Houston at a low level for at least six to eight weeks, a new study has found. Houston is the first U.S. city to find all of the variants, including those recently reported in California and New York and the ones found in Brazil, Britain and South Africa.

The discovery mainly highlights how little is actually known about the variants — their true whereabouts, prevalence and impact — as no other American city has the data in place to make such a survey possible.

Since last March, a team of researchers led by Dr. James Musser, chair of the department of pathology and genomic medicine at Houston Methodist Hospital, have been sequencing the viral genomes drawn from patients — 20,000 genomes so far.

Dr. Musser said the team had also analyzed detailed information on the infected patients. By linking the data sets, scientists can begin to ask vital questions: How do these variants affect the ability of the virus to spread, if at all? Do they make the symptoms any more or less severe? Are they any more or less resistant to vaccines, pre-existing immunity or treatment with monoclonal antibodies?

Before the pandemic took off in Houston, the team had set up a plan to match any variant it found with the clinical course of patients infected with it.

“If you don’t have the sequencing matched up with patient data, they are far, far less interesting, if not uninterpretable,” Dr. Musser said.

To Dr. Musser’s knowledge, Houston is the only city with the patient and sequencing data to address those questions. Iceland is undertaking a similar effort, he said, and he expects Israel to do so, also.

So far, researchers have tried to infer the effect of variants by looking at their prevalence in different populations and by doing laboratory studies. Those can provide important clues, Dr. Musser said, but to make the best use of those data, they must be linked to patient data.

Some critics, including Dr. Eric Topol, the founder and director of the Scripps Research Translational Institute, have said that the attention given to the succession of new variants — “scariants,” he has called them — has done little more than frighten the public.

Dr. Musser agreed, referring to such reports as “mutant porn.” Highlighting the existence of variants without indicating whether they make any functional difference to real-world patients was no more enlightening than collecting stamps or identifying the birds flying overhead, he said: “‘There’s a bird. There’s another bird.’”

He added: “I think the crucial thing in all of this is that it is extraordinarily difficult for both the medical and lay public to really sort through all this noise about variants. At the end of the day, does any of this mean a hill of beans to anyone?”

“The big issue is to try to get things toned down.”

Vaccines were prepared at a community center in Rohnert Park, Calif., in January.
Credit…Jim Wilson/The New York Times

Coronavirus vaccinations can cause enlarged lymph nodes in the armpit or near the collarbone, which may be mistaken for a sign of cancer.

Doctors are seeing more and more of these swollen nodes in recently immunized people, and are trying to allay fears and help patients avoid needless testing for a harmless condition that will go away in a few weeks.

The swelling is a normal reaction by the immune system, and occurs under the arm where the shot was given. Patients may not notice it. But it shows up on mammograms and other scans, resembling images that can indicate the spread of cancer from the breast or elsewhere in the body.

“I am particularly eager to get the word out to all the patients undergoing surveillance after successful prior treatment of cancer,” said Dr. Constance D. Lehman, an author of two journal articles on the problem and the chief of breast imaging at the Massachusetts General Hospital. “I can’t imagine the anxiety of getting the scan and hearing, ‘We found a node that is large. We don’t think it’s cancer but can’t tell,’ or worse, ‘We think it might be cancer.’”

Dr. Lehman said imaging centers should ask patients if they have had Covid-19 inoculations and record the date of the shot and the arm in which it was given.

Her clinic includes this advisory in a letter to patients whose screenings detect swelling but no other abnormalities: “The lymph nodes in your armpit area that we see on your mammogram are larger on the side where you had your recent Covid-19 vaccine. Enlarged lymph nodes are common after the Covid-19 vaccine and are your body’s normal reaction to the vaccine. However, if you feel a lump in your armpit that lasts for more than six weeks after your vaccination, you should let your health care provider know.”

One way to avoid the problem would be to postpone routine mammograms and other imaging for at least six weeks after the last dose of vaccine, according to an article by an expert panel in the journal Radiology.

But the panel also cautioned that nonroutine imaging, needed to help deal with an illness or other symptoms that might indicate cancer, should not be delayed. Nor should immunization.

In recently vaccinated people who have cancer and develop enlarged lymph nodes, it may be necessary to perform more tests, including a biopsy of the nodes, Dr. Lehman said.

The vaccines already in wide use in the United States are given in two doses several weeks apart, while the newly authorized Johnson & Johnson vaccine is given in a single dose.
Credit…Pool photo by Timothy D Easley

A third effective weapon was added to America’s arsenal against the coronavirus on Saturday when the Food and Drug Administration granted emergency use authorization for a vaccine developed by Johnson & Johnson.

The company said it would start shipping millions of doses early this week, and would provide the United States with 100 million doses by the end of June. Together with 600 million doses of the nation’s first two authorized vaccines, made by Pfizer-BioNTech and Moderna, that are due to be delivered over the next four months, that ought to be enough to cover every American adult who wants to be vaccinated.

The new vaccine differs markedly from the two already in use in the United States. Here is how they compare.

The Johnson & Johnson vaccine is administered in a single shot, while the Pfizer-BioNTech and Moderna vaccines are given in two shots several weeks apart.

The Johnson & Johnson vaccine uses a different method to prime the body to fight off Covid-19: a viral vector called Ad26. Viral vectors are common viruses that have been genetically altered so that they do not cause illness but can still cause the immune system to build up its defenses. The Pfizer-BioNTech and Moderna vaccines use messenger RNA to do that.

The Johnson & Johnson vaccine is rated as highly effective at preventing serious illness and death, as the Pfizer-BioNTech and Moderna vaccines are. It is also very effective at preventing milder illness, though a bit less so than those two. It appears to do well against the highly contagious B.1.351 variant, first identified in South Africa, that has given at least one other vaccine candidate trouble.

The Johnson & Johnson vaccine does not have to be stored at extremely low temperatures like the Pfizer-BioNTech vaccine. It can safely be kept in an ordinary refrigerator for three months, much longer than the Moderna vaccine, which spoils after a month if not kept frozen.

The Johnson & Johnson vaccine appears to be less prone than the Pfizer-BioNTech and Moderna vaccines to trigger the kinds of side effects that require monitoring after the injection, which may make it more suitable for use at drive-through vaccination sites. There have been reports that side effects tend to be felt more strongly after second doses, which the Johnson & Johnson vaccine does not require.

As the pandemic wrought economic devastation around the country, states were forced to revise their revenue forecasts and prepare for the worst, but new data shows that, for many, the worst didn’t come. One big reason: $600-a-week federal supplements that allowed people to keep spending — and states to keep collecting sales tax revenue — even when they were jobless, along with the usual state unemployment benefiIn Washington, lawmakers disagree on whether states should get no-strings-attached federal aid — an issue that has long been a stumbling block for state and local governments receiving a direct infusion of cash from Congress. President Biden’s $1.9 trillion federal stimulus bill contains $350 billion in relief for state, local and tribal governments and a $400 weekly unemployment supplement.

Republicans have mostly said no to this kind of federal aid, casting it as a bailout for spendthrift blue states. Democrats have argued the opposite, saying that states face dire fiscal consequences without aid.

By some measures, states in the past year ended up collecting nearly as much revenue in 2020 as they did in 2019. A J.P. Morgan survey called 2020 “virtually flat” with 2019, based on the 47 states that report their tax revenues every month, or all except Alaska, Oregon and Wyoming. And a researcher at the Urban-Brookings Tax Policy Center, a nonpartisan think tank, found that total state revenues from April through December were down just 1.8 percent from the same period in 2019.

In short, the states struggled far less during the pandemic than in previous recessions. During the Great Recession, Congress sent supplements of just $25 a week. This time, Washington sent supplements of $600 a week. Since the pandemic ravaged low-wage sectors like retail sales and restaurants, adding $600 a week to the lowest unemployment benefits pushed many recipients’ purchasing power above what they had while working.

Emily Cochrane contributed reporting.

Ursula von der Leyen, the president of the European Commission, speaking at a press conference at the end of a European Union summit in Brussels on Friday.
Credit…Pool photo by Johanna Geron

The European Union will propose issuing a certificate called a Digital Green Pass that would let people who have been vaccinated against the coronavirus travel more freely, Ursula von der Leyen, the president of the European Commission, said on Monday.

“The Digital Green Pass should facilitate Europeans’ lives,” Ms. von der Leyen wrote on Twitter. “The aim is to gradually enable them to move safely in the European Union or abroad — for work or tourism.”

The announcement followed an intense debate at a virtual meeting last week that laid bare deep divisions among leaders of the bloc’s 27 member nations.

Tourism-dependent nations like Greece have been pushing for such a plan to help salvage the summer travel season, while others, led by France, have been wary of the potential for discrimination between vaccinated and non-vaccinated Europeans, as well as possible infringement on personal data protection.

“In the future, it will certainly be good to have such a certificate, but that will not mean that only those who have such a passport will be able to travel,” Chancellor Angela Merkel of Germany said after the meeting last week.

Vaccination efforts in the European Union have generally gotten a sluggish start. Just 5 percent of the bloc’s population has received at least one shot of vaccine so far. But the certificates will go beyond vaccination status to include the holder’s wider medical history concerning the virus, according to Christian Wigand, the commission’s spokesman.

“We will also be looking at other categories of information to avoid discrimination of citizens, such as test results and statements of recovery,” Mr. Wigand said on Monday.

Getting the system set up and issuing certificates would take at least three months, the commission said. It was not immediately clear what legislative and technical steps would be required, nor whether the system would extend beyond European Union citizens.

The commission said there should be a way to scale it up globally, in cooperation with the World Health Organization. But when pressed for further details, Mr. Wigand asked for “a little bit of patience,” explaining that “this is all very fresh.”

After the meeting with the 27 national leaders last week, Ms. von der Leyen said: “It is important to have a European solution, because otherwise others will go into this vacuum. Google and Apple are already offering solutions to the W.H.O., and this is sensitive information.” Apple said afterward that Ms. von der Leyen may have misunderstood and that the company was not currently offering such a solution.



Thank you for dropping in and checking this news update about current USA Business and Political news named “Covid-19: The U.S. Is Edging Toward Normal, Alarming Some Officials”. This story was shared by MyLocalPages as part of our USA news services.

#Covid19 #Edging #Normal #Alarming #Officials



Source link

Gov. Andy Beshear declares state of emergency


Thank you for stopping by and checking out this news article about the latest USA Business news items published as “Gov. Andy Beshear declares state of emergency”. This article was presented by MyLocalPages Australia as part of our USA news services.

#Gov #Andy #Beshear #declares #state #emergency



Source link

DHS chief defends Biden admin on immigration, says Trump ‘gutted’ system


Mayorkas urged patience while they rebuild the system “virtually from scratch.”

“I learned that we did not have the facilities available or equipped to administer the humanitarian laws that our Congress passed years ago,” Mayorkas said in his first appearance at a White House briefing. “We did not have the personnel policies, procedures for training to administer those laws. Quite frankly, the entire system was gutted.”

Trump’s immigration approach largely focused on hardline enforcement and security measures including the appropriation of billions of dollars for a border wall, which Biden stopped.

“What we are seeing now at the border is the immediate result of the dismantlement of the system and the time that it takes to rebuild it virtually from scratch,” Mayorkas said. “We have, though, already begun.”

The Trump administration also took on a policy called “zero-tolerance” which resulted in the separation of thousands of migrant parents from their children. Hundreds remain separated to date and — among his first actions on immigration — Biden created a task force chaired by Mayorkas to reunite the separated families.

“We will explore lawful pathways for them to remain in the United States, and to address the family needs so we are acting as restoratively as possible,” Mayorkas said.

Despite what he called these “challenges,” he insisted the U.S. was not in the midst of a “crisis” at the southern border.

The number of arrests made each month at the border has been increasing since April 2020, which has posed a central challenge for the Biden administration as it works to roll back many of the Trump-era enforcement measures.

“We need individuals to wait,” Mayorkas said. “And I will say that they will wait with a goal in mind. And that is our ability to rebuild as quickly as possible a system so that they don’t have to take the dangerous journey, and we can enable them to access humanitarian relief from their countries of origin.”

Mayorkas insisted that the new administration is not treating migrants the same as the Trump administration.

However, Biden has yet to revoke Trump-era protocols brought down after the pandemic began to turn away or “expel” the vast majority of migrants at the border. This use of this section of public health code known as “Title 42” has been condemned by human rights observers as immigrant advocates for the limits it places on access to legal avenues for obtaining asylum status.

Dozens of advocacy organizations wrote to the Biden administration earlier this month calling for a swift end to the use of “Title 42,” claiming the Centers for Disease Control and Prevention had been pressured by Trump’s immigration hawks into issuing the order.

Mayorkas rejected the comparison to the Trump administration’s policies, noting that, under Biden, authorities at the border are not “expelling” unaccompanied children.

Thank you for stopping to visit My Local Pages. We Hope you enjoyed checking this news release regarding USA Business, International and Political news titled “DHS chief defends Biden admin on immigration, says Trump ‘gutted’ system”. This news article is posted by MyLocalPages Australia as part of our news aggregator services.

#DHS #chief #defends #Biden #admin #immigration #Trump #gutted #system



Source link